Hyphens Pharma International Limited (SGX:1J5)

SGXC:1J5 Ratios and Metrics

Market cap in millions SGD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	105	88	88	103	93	95
Market Cap Growth	16.07%	-0.10%	-14.81%	11.67%	-2.12%	50.00%
Enterprise Value	100	81	61	82	66	75
Last Close Price	0.34	0.27	0.26	0.26	0.23	0.24
PE Ratio	16.62	8.64	10.29	9.11	13.53	15.36
Forward PE	9.42	7.75	8.88	9.49	12.88	14.58
PS Ratio	0.57	0.45	0.52	0.64	0.74	0.78
PB Ratio	1.55	1.18	1.34	1.47	1.69	2.01
P/TBV Ratio	2.56	1.90	2.24	2.07	2.54	2.41
P/FCF Ratio	15.36	-	16.50	6.34	17.36	25.18
P/OCF Ratio	13.55	1467.17	15.61	6.13	15.34	22.91
PEG Ratio	0.96	1.62	1.62	1.62	1.62	1.54
EV/Sales Ratio	0.54	0.42	0.36	0.50	0.52	0.62
EV/EBITDA Ratio	7.74	5.45	4.83	5.08	7.24	12.18
EV/EBIT Ratio	10.00	6.08	5.54	5.65	8.45	15.27
EV/FCF Ratio	14.70	-	11.43	5.00	12.34	20.00
Debt / Equity Ratio	0.17	0.19	0.10	0.08	0.15	0.11
Debt / EBITDA Ratio	0.90	0.86	0.49	0.33	0.82	0.71
Debt / FCF Ratio	1.72	-	1.28	0.35	1.53	1.32
Asset Turnover	1.46	1.52	1.45	1.52	1.39	1.50
Inventory Turnover	3.90	4.24	4.68	4.30	3.72	5.61
Quick Ratio	1.21	1.18	1.30	1.67	1.12	1.67
Current Ratio	1.80	1.84	1.87	2.24	1.74	2.27
Return on Equity (ROE)	10.17%	15.47%	12.61%	18.25%	13.44%	13.51%
Return on Assets (ROA)	4.96%	6.50%	5.85%	8.45%	5.39%	3.81%
Return on Capital (ROIC)	8.04%	10.34%	9.26%	13.01%	8.46%	6.17%
Return on Capital Employed (ROCE)	14.40%	17.10%	15.40%	19.40%	13.80%	9.60%
Earnings Yield	6.15%	11.58%	9.72%	10.97%	7.39%	6.51%
FCF Yield	6.51%	-1.28%	6.06%	15.78%	5.76%	3.97%
Dividend Yield	4.55%	5.55%	3.28%	4.22%	2.91%	2.62%
Payout Ratio	71.72%	26.05%	169.97%	18.23%	27.21%	48.74%
Buyback Yield / Dilution	-1.38%	-1.74%	0.27%	-2.66%	-0.60%	-0.05%
Total Shareholder Return	3.23%	3.81%	3.55%	1.57%	2.31%	2.57%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.